11
Sep
2024
14:00
BST
09:00
EDT
Webinar
Medical Options for Advanced HFpEF/HFmrEF Patients: An Expert-Guided Virtual Ward Round
-
Views:
4921
-
Likes:
21
Overview
Join us for an unparalleled educational journey dedicated to tackling the complexities of managing HFpEF and HFmrEF patients. This CME-accredited live roundtable is chaired by Dr Biykem Bozkurt (Baylor College of Medicine, US) and features insights from renowned experts Prof Pardeep Jhund (University of Glasgow, UK) and Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, US).
During the roundtable, our distinguished faculty will delve into two case studies from part one of the programme, offering their expert perspectives on managing high-risk HFmrEF/HFpEF patients. The discussion will focus on current guidelines, evidence-based approaches and will highlight critical gaps and challenges. Engage with our experts during a live audience Q&A session and enhance your understanding of these complex conditions.
Register now to secure your spot and gain valuable knowledge from leading figures in the field of heart failure management. Don't miss this opportunity to elevate your professional practice.
Accreditation
Medical Options for Advanced HFpEF/HFmrEF Patients: An Expert-Guided Virtual Ward Round's programme has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME credit, equating to 1 hour of effective education time. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.
Case Studies
Click the link below to see Part 1 of the programme.
This programme is supported by an unrestricted educational grant from Bayer.
This education was developed by Radcliffe Medical Communications (Eire) Ltd.
Faculty:
Biykem Bozkurt
Pardeep Jhund
Muthiah Vaduganathan
Agenda
Learning Objectives
- Describe the current limitations of HFmrEF/HFpEF GDMT in advanced patients
- Select appropriate patients for advanced medical therapy
- Recall recent trial data for novel therapeutic approaches
- Use expert guidance to develop an evidence-based approach to managing advanced HFmrEF/HFpEF
Target Audience
- Cardiologists
- Internists
- Heart Failure Specialists
- General Practitioners
- Nurse Practitioners
- Cardiovascular Nurses
- Allied Healthcare Professionals
Faculty Biographies
Biykem Bozkurt
Dr Biykem Bozkurt is the Immediate Past President of the Heart Failure Society of America.
Dr Bozkurt is a Professor of Medicine, an advanced heart failure and cardiac transplantation specialist, Medical Care Line Executive (Medicine Department Chair) at the DeBakey VA Medical Center; W.A. “Tex” and Deborah Moncrief, Jr., Chair; Mary and Gordon Cain Chair; Vice-Chair of Department of Medicine; Director of the Winters Center for Heart Failure and Associate Director of Cardiovascular Research Institute at Baylor College of Medicine.
Pardeep Jhund
Dr Pardeep Jhund is a Reader in Cardiology at the University of Glasgow, UK.
He trained in medicine at the University of Glasgow, and completed his general medical training in Edinburgh. During this time he also graduated with a MSc in Epidemiology from the London School of Hygiene and Tropical Medicine, London, UK.
Prior to this, he graduated from the University of Glasgow with a PhD in cardiovascular epidemiology, under the tutelage of Prof John McMurray, and completed his fellowship at The Brigham and Women’s Hospital, Boston, US.
Dr Jhund has a special interest in heart failure, around which he has published widely in leading international journals.
Muthiah Vaduganathan
Dr Muthiah Vaduganathan is a Cardiologist and Clinical Trialist at Brigham and Women’s Hospital and Harvard Medical School, Boston, US. He is co-director of the Center for Cardiometabolic Implementation Science at Brigham and Women’s Hospital. He serves as an Associate Editor of JACC and as US national ambassador to the ESC Heart Failure Association. His research focuses on drug development, clinical trials, and implementation of cardio-kidney-metabolic therapies, and he has authored or co-authored more than 700 peer-reviewed publications. He participates on study leadership of ongoing advanced-phase trials in cardio-kidney-metabolism and heart failure.